Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyan Liu

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Cell|May 2, 2017
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus MonkeysMalika Aid, Peter Abbink, Rafael A Larocca, et al.
Science Immunology|August 9, 2022
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaquesJinyan Liu, Jingyou Yu, Katherine McMahan, et al.
Science Translational Medicine|October 15, 2025
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaquesNinaad Lasrado, Liping Wang, Jinyan Liu, et al.
Cell|September 21, 2023
Mpox infection protects against re-challenge in rhesus macaquesMalika Aid, Michaela Sciacca, Katherine McMahan, et al.
Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.
Cell|April 18, 2016
Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus MonkeysDan H Barouch, Khader Ghneim, William J Bosche, et al.
The New England Journal of Medicine|October 14, 2021
Differential Kinetics of Immune Responses Elicited by Covid-19 VaccinesAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Science Translational Medicine|February 22, 2022
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaquesXuan He, Malika Aid, Abishek Chandrashekar, et al.
Annals of Internal Medicine|February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus VaccineNadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Cell|May 2, 2017
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus MonkeysMalika Aid, Peter Abbink, Rafael A Larocca, et al.
Science Immunology|August 9, 2022
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaquesJinyan Liu, Jingyou Yu, Katherine McMahan, et al.
Science Translational Medicine|October 15, 2025
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaquesNinaad Lasrado, Liping Wang, Jinyan Liu, et al.
Cell|September 21, 2023
Mpox infection protects against re-challenge in rhesus macaquesMalika Aid, Michaela Sciacca, Katherine McMahan, et al.
Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.
Cell|April 18, 2016
Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus MonkeysDan H Barouch, Khader Ghneim, William J Bosche, et al.
The New England Journal of Medicine|October 14, 2021
Differential Kinetics of Immune Responses Elicited by Covid-19 VaccinesAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Science Translational Medicine|February 22, 2022
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaquesXuan He, Malika Aid, Abishek Chandrashekar, et al.
Annals of Internal Medicine|February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus VaccineNadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Pageof 23